These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36314944)

  • 1. Very severe immune aplastic anemia after mRNA vaccination against COVID-19 responds well to immunosuppressive therapy: clinical characteristics and comparison to previous reports.
    Woo S; Kim B; Lee SC; Kim MS; Yoon YA; Choi YJ
    Hematology; 2022 Dec; 27(1):1191-1195. PubMed ID: 36314944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired aplastic anemia following SARS-CoV-2 vaccination.
    Röth A; Bertram S; Schroeder T; Haverkamp T; Voigt S; Holtkamp C; Klump H; Wörmann B; Reinhardt HC; Alashkar F
    Eur J Haematol; 2022 Aug; 109(2):186-194. PubMed ID: 35592930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report.
    Matsui K; Kamata W; Mochida Y; Ishioka K; Moriya H; Hidaka S; Ohtake T; Tamai Y; Kobayashi S
    BMC Nephrol; 2022 Apr; 23(1):136. PubMed ID: 35392836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe aplastic anemia after COVID-19 mRNA vaccination: Causality or coincidence?
    Tabata S; Hosoi H; Murata S; Takeda S; Mushino T; Sonoki T
    J Autoimmun; 2022 Jan; 126():102782. PubMed ID: 34920343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan.
    Chen CY; Chen TT; Hsieh CY; Lien MY; Yeh SP; Chen CC
    Int J Hematol; 2023 Jan; 117(1):149-152. PubMed ID: 36057889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune pathogenesis, immunosuppressive therapy and pharmacological mechanism in aplastic anemia.
    Pan P; Chen C; Hong J; Gu Y
    Int Immunopharmacol; 2023 Apr; 117():110036. PubMed ID: 36940553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia.
    Chen HF; Xu BX; Shen HS; Li ZY; Jin LJ; Tang JQ; Wang J; Zhu JJ; Qin LM; Cui QY; Ren YY; Wu TQ
    Drug Des Devel Ther; 2014; 8():1299-305. PubMed ID: 25246771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion to mRNA SARS-CoV-2 vaccines in patients with autoimmune cytopenias and bone marrow failures.
    Fattizzo B; Bortolotti M; Giannotta JA; Consonni D; Cantoni S; Barcellini W
    Sci Rep; 2022 May; 12(1):7743. PubMed ID: 35546175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemia.
    Rajput RV; Ma X; Boswell KL; Gaudinski M; Gordon I; Novik L; Groarke EM; Lotter J; Superata J; Rios OJ; Darden I; Lin BC; Jean-Baptiste N; Carroll R; Moore C; Trost J; Naisan M; Willis J; Serebryannyy L; Wang JL; Prabhakaran M; Narpala SR; Koup RA; McDermott A; Wu CO; Young NS; Patel BA
    Br J Haematol; 2022 Dec; 199(5):679-687. PubMed ID: 36128909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic choices in immune aplastic anemia.
    Scheinberg P
    F1000Res; 2020; 9():. PubMed ID: 32953089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of Epstein-Barr virus-associated plasmacytic lymphoproliferative disorder after antithymocyte globulin therapy for aplastic anemia: a case report with review of the literature.
    Nakanishi R; Ishida M; Hodohara K; Okuno H; Yoshii M; Horinouchi A; Shirakawa A; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2014; 7(4):1748-54. PubMed ID: 24817974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of severe aplastic anaemia after SARS-CoV-2 vaccination.
    Cecchi N; Giannotta JA; Barcellini W; Fattizzo B
    Br J Haematol; 2022 Mar; 196(6):1334-1336. PubMed ID: 34783367
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Trends in Nontransplant Therapy for Acquired Aplastic Anemia.
    Ding S; Fu R
    Curr Pharm Des; 2022; 28(21):1730-1737. PubMed ID: 35440301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aplastic anemia].
    Čermák J
    Vnitr Lek; 2018; 64(5):501-507. PubMed ID: 30193518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive therapy in severe aplastic anemia.
    Patel BA; Townsley DM; Scheinberg P
    Semin Hematol; 2022 Jan; 59(1):21-29. PubMed ID: 35491055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effectiveness of Rapamycin Combined with Eltrombopag in Murine Models of Immune-Mediated Bone Marrow Failure.
    Ding S; Liang X; Zhang T; Fu R
    J Immunol Res; 2020; 2020():1798795. PubMed ID: 33123600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.
    Dorr V; Doolittle G; Woodroof J
    Am J Hematol; 1996 Jun; 52(2):108-13. PubMed ID: 8638630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.